002589 瑞康医药
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资531,9010.00%531,901655,388435,948638,749
投资性房地产576,070-1.87%587,042605,263625,422644,276
固定资产1,902,250-1.22%1,925,6711,845,5651,975,3471,922,303
在建工程321,1424.49%307,339429,340315,367549,585
无形资产428,938-2.71%440,890552,391624,208478,346
商誉146,6680.00%146,668146,668146,685620,267
其他非流动资产976,452-1.54%991,734935,5991,389,680871,241
4,883,421-0.97%4,931,2465,170,2135,512,6575,724,766

流动资产
货币资金4,974,694-0.18%4,983,6645,060,7875,340,2124,578,740
应收账款3,833,240-0.82%3,865,0303,762,9884,112,36910,285,101
存货690,052-6.08%734,7411,119,070954,5152,067,938
其他流动资产1,658,93010.77%1,497,6401,596,2482,412,4603,740,430
11,156,9160.68%11,081,07511,539,09312,819,55620,672,209

流动负债
短期借款6,331,6893.94%6,091,6796,556,0613,839,8354,165,027
应付票据590,583-2.12%603,383448,5995,157,3596,435,746
应付帐款2,557,147-7.98%2,778,8453,274,0302,557,3923,355,303
其他流动负债459,3620.00%459,357482,428913,8502,551,708
9,938,7820.06%9,933,26410,761,11812,468,43716,507,784
流动资产净值1,218,1346.13%1,147,811777,975351,1194,164,425
资产总额减流动负债6,101,5550.37%6,079,0565,948,1885,863,7779,889,191

非流动负债
长期借款358,4489.59%327,081261,27467,20048,500
应付债券0--0000
其他非流动负债54,254-5.41%57,35749,93745,244147,534
412,7027.35%384,438311,211112,444196,034

总权益
    实收股本1,504,7100.00%1,504,7101,504,7101,504,7101,504,710
    储备项目4,004,395-0.71%4,033,0813,943,0833,902,6226,062,325
股东权益5,509,106-0.52%5,537,7925,447,7945,407,3327,567,036
非控股权益179,74714.62%156,826189,183344,0002,126,121